Manikandan Subramanian: In Our Latest Study We Uncover a Key Mechanism Behind Clearance of Dying Cells Failure
Manikandan Subramanian, Group Leader and Deputy Director of Research at the William Harvey Research Institute, Barts and The London School of Medicine, shared a post on LinkedIn:
“Clearance of dying cells—lovingly called efferocytosis—is a vital housekeeping role carried out by macrophages. But when this process fails, tissues buckle under pressure of mounting debris and start to dysfunction. In diseases like atherosclerosis, this breakdown can ultimately trigger heart attacks and strokes.
In our latest study, published in Circulation Research and led by Aarushi Singhal we uncover a key mechanism behind this failure. We found that endoplasmic reticulum stress activates the protein TRIB3, which then blocks macrophages from forming the membrane structures needed to engulf and clear dead cells.
In other words, TRIB3 acts as a brake on efferocytosis in atherosclerotic plaques—and targeting it could open new therapeutic pathways for cardiovascular disease.
Title: TRIB3 Links Endoplasmic Reticulum Stress to Impaired Efferocytosis in Atherosclerosis
Authors: Aarushi Singhal, Stefan Russo, Umesh Kumar Dhawan, Kunzangla Bhutia, Christopher G. Bell, Hedayatullah Hayat, Thomas D. Nightingale, Monica de Gaetano, Orina Belton, Eoin Brennan, Patricia B. Munroe, Catherine Godson, Mary Barry, Carol C. Shoulders, Heather L. Wilson, Guillermo Velasco, Endre Kiss-Toth, Manikandan Subramanian
Curious to learn more? Read the full paper here.
A huge thanks to Barts Charity and the British Heart Foundation for supporting this work, and to all our fantastic collaborators who made this possible.”
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial
-
Feb 23, 2026, 11:37Charles Okyere Boadu: Blood Donation Helps Lower Your Risk of Stroke and Organ Damage
-
Feb 23, 2026, 11:29Emma Lefrancais: Uncovering A Key Role for The IL-33/ST2 Axis in Platelet Biology with Lucie Gelon
-
Feb 22, 2026, 14:16Ilenia Calcaterra: From Representation to Intellectual Independence in Women in Science
-
Feb 22, 2026, 13:27Pete Stibbs: New AHA and ACC PE Guidelines Finally Align with Real Clinical Practice